Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James G Carter

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Health Research Policy and Systems|June 26, 2016
United Kingdom health research analyses and the benefits of shared dataJames G Carter, Beverley J Sherbon, Ian S Viney
Acta Ophthalmologica|August 27, 2009
β-Defensin 1 haplotype associated with postoperative endophthalmitisJames G Carter, Stephanie K West, Sally Painter, et al.
The Journal of Physiology|November 22, 2016
Differential regulation of blood flow-induced neovascularization and mural cell recruitment by vascular endothelial growth factor and angiopoietin signallingOliver A Stone, James G Carter, P Charles Lin, et al.
Angiogenesis|October 3, 2014
The carboxyl terminus of VEGF-A is a potential target for anti-angiogenic therapyJames G Carter, Melissa V R Gammons, Gopinath Damodaran, et al.
Investigative Ophthalmology & Visual Science|April 29, 2008
VEGF polymorphisms are associated with severity of diabetic retinopathyAmanda J Churchill, James G Carter, Conor Ramsden, et al.
American Journal of Cancer Research|August 14, 2015
Circulating levels of anti-angiogenic VEGF-A isoform (VEGF-Axxxb) in colorectal cancer patients predicts tumour VEGF-A ratiosJohn Bunni, Golda Shelley-Fraser, Kirsty Stevenson, et al.
Human Molecular Genetics|August 31, 2006
VEGF polymorphisms are associated with neovascular age-related macular degenerationAmanda J Churchill, James G Carter, Helen C Lovell, et al.
Plos One|August 13, 2013
Detection of VEGF-A(xxx)b isoforms in human tissuesDavid O Bates, Athina Mavrou, Yan Qiu, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Health Research Policy and Systems|June 26, 2016
United Kingdom health research analyses and the benefits of shared dataJames G Carter, Beverley J Sherbon, Ian S Viney
Acta Ophthalmologica|August 27, 2009
β-Defensin 1 haplotype associated with postoperative endophthalmitisJames G Carter, Stephanie K West, Sally Painter, et al.
The Journal of Physiology|November 22, 2016
Differential regulation of blood flow-induced neovascularization and mural cell recruitment by vascular endothelial growth factor and angiopoietin signallingOliver A Stone, James G Carter, P Charles Lin, et al.
Angiogenesis|October 3, 2014
The carboxyl terminus of VEGF-A is a potential target for anti-angiogenic therapyJames G Carter, Melissa V R Gammons, Gopinath Damodaran, et al.
Investigative Ophthalmology & Visual Science|April 29, 2008
VEGF polymorphisms are associated with severity of diabetic retinopathyAmanda J Churchill, James G Carter, Conor Ramsden, et al.
American Journal of Cancer Research|August 14, 2015
Circulating levels of anti-angiogenic VEGF-A isoform (VEGF-Axxxb) in colorectal cancer patients predicts tumour VEGF-A ratiosJohn Bunni, Golda Shelley-Fraser, Kirsty Stevenson, et al.
Human Molecular Genetics|August 31, 2006
VEGF polymorphisms are associated with neovascular age-related macular degenerationAmanda J Churchill, James G Carter, Helen C Lovell, et al.
Plos One|August 13, 2013
Detection of VEGF-A(xxx)b isoforms in human tissuesDavid O Bates, Athina Mavrou, Yan Qiu, et al.
Pageof 1